These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 29218569

  • 1. Toxin positivity and tcdB gene load in broad-spectrum Clostridium difficile infection.
    Kim HN, Kim H, Moon HW, Hur M, Yun YM.
    Infection; 2018 Feb; 46(1):113-117. PubMed ID: 29218569
    [Abstract] [Full Text] [Related]

  • 2. Laboratory and Clinical features of EIA Toxin-positive and EIA Toxin-negative Community-acquired Clostridium difficile Infection.
    Patel H, Randhawa J, Nanavati S, Marton LR, Baddoura WJ, DeBari VA.
    Ann Clin Lab Sci; 2015 Feb; 45(3):333-9. PubMed ID: 26116599
    [Abstract] [Full Text] [Related]

  • 3. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
    Deniz U, Ulger N, Aksu B, Karavuş M, Söyletir G.
    Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
    [Abstract] [Full Text] [Related]

  • 4. Colonization of toxigenic Clostridium difficile among ICU patients: a prospective study.
    Zhang X, Wang X, Yang J, Liu X, Cai L, Zong Z.
    BMC Infect Dis; 2016 Aug 09; 16():397. PubMed ID: 27506470
    [Abstract] [Full Text] [Related]

  • 5. Composition of gut microbiota in patients with toxigenic Clostridioides (Clostridium) difficile: Comparison between subgroups according to clinical criteria and toxin gene load.
    Han SH, Yi J, Kim JH, Lee S, Moon HW.
    PLoS One; 2019 Aug 09; 14(2):e0212626. PubMed ID: 30785932
    [Abstract] [Full Text] [Related]

  • 6. High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients.
    Toltzis P, Nerandzic MM, Saade E, O'Riordan MA, Smathers S, Zaoutis T, Kim J, Donskey CJ.
    Infect Control Hosp Epidemiol; 2012 Feb 09; 33(2):175-9. PubMed ID: 22227987
    [Abstract] [Full Text] [Related]

  • 7. Can a toxin gene NAAT be used to predict toxin EIA and the severity of Clostridium difficile infection?
    Garvey MI, Bradley CW, Wilkinson MAC, Holden E.
    Antimicrob Resist Infect Control; 2017 Feb 09; 6():127. PubMed ID: 29270290
    [Abstract] [Full Text] [Related]

  • 8. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
    Erb S, Frei R, Strandén AM, Dangel M, Tschudin-Sutter S, Widmer AF.
    Clin Microbiol Infect; 2015 Nov 09; 21(11):998.e9-998.e15. PubMed ID: 26232535
    [Abstract] [Full Text] [Related]

  • 9. Clostridioides difficile PCR Tcdb Cycle Threshold predicts toxin EIA positivity but not severity of infection.
    Mah R, Locher K, Steiner TS, Stefanovic A.
    Anaerobe; 2023 Aug 09; 82():102755. PubMed ID: 37406762
    [Abstract] [Full Text] [Related]

  • 10. Two-step glutamate dehydrogenase antigen real-time polymerase chain reaction assay for detection of toxigenic Clostridium difficile.
    Goldenberg SD, Cliff PR, Smith S, Milner M, French GL.
    J Hosp Infect; 2010 Jan 09; 74(1):48-54. PubMed ID: 19900734
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcomes and treatment necessity in patients with toxin-negative Clostridioides difficile stool samples.
    Cho DH, Kim SH, Jeon CH, Kim HT, Park KJ, Kim J, Kwak J, Kwan BS, Kong S, Lee JW, Kim KM, Wi YM.
    Ann Clin Microbiol Antimicrob; 2024 Apr 25; 23(1):35. PubMed ID: 38664689
    [Abstract] [Full Text] [Related]

  • 12. Molecular test to determine toxigenic capabilities in GDH-positive, toxin-negative samples: evaluation of the Portrait toxigenic C. difficile assay.
    Finch LS, Duncan CM.
    Br J Biomed Sci; 2013 Apr 25; 70(2):62-6. PubMed ID: 23888607
    [Abstract] [Full Text] [Related]

  • 13. Detection of clostridium difficile antigen and toxin in stool specimens: Comparison of the C. difficile quik chek complete enzyme immunoassay and GeneXpert C. difficile polymerase chain reaction assay.
    Senok AC, Aldosari KM, Alowaisheq RA, Abid OA, Alsuhaibani KA, Khan MA, Somily AM.
    Saudi J Gastroenterol; 2017 Apr 25; 23(4):259-262. PubMed ID: 28721981
    [Abstract] [Full Text] [Related]

  • 14. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL, Silva ROS, Nader AP, Lobato FCF, Vilela EG.
    J Gastroenterol Hepatol; 2018 Feb 25; 33(2):393-396. PubMed ID: 28730697
    [Abstract] [Full Text] [Related]

  • 15. Toxin B PCR Amplification Cycle Threshold Adds Little to Clinical Variables for Predicting Outcomes in Clostridium difficile Infection: a Retrospective Cohort Study.
    Origüen J, Orellana MÁ, Fernández-Ruiz M, Corbella L, San Juan R, Ruiz-Ruigómez M, López-Medrano F, Lizasoain M, Ruiz-Merlo T, Maestro-de la Calle G, Parra P, Villa J, Delgado R, Aguado JM.
    J Clin Microbiol; 2019 Feb 25; 57(2):. PubMed ID: 30463889
    [Abstract] [Full Text] [Related]

  • 16. Comparison of enzyme immunoassays and rapid diagnostic tests for clostridium difficile glutamate dehydrogenase and toxin a + B to toxinogenic culture on a highly selective chromogenic medium.
    Olling A, Leidinger H, Hoffmann R.
    Eur J Clin Microbiol Infect Dis; 2016 Oct 25; 35(10):1655-9. PubMed ID: 27323765
    [Abstract] [Full Text] [Related]

  • 17. Molecular characterization of Clostridium difficile isolated from carriage and association of its pathogenicity to prevalent toxic genes.
    Abuderman AA, Mateen A, Syed R, Sawsan Aloahd M.
    Microb Pathog; 2018 Jul 25; 120():1-7. PubMed ID: 29684543
    [Abstract] [Full Text] [Related]

  • 18. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
    Shin BM, Lee EJ, Kuak EY, Yoo SJ.
    Anaerobe; 2009 Dec 25; 15(6):266-9. PubMed ID: 19772927
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the clinical course of Clostridium difficile infection in glutamate dehydrogenase-positive toxin-negative patients diagnosed by PCR to those with a positive toxin test.
    Origüen J, Corbella L, Orellana MÁ, Fernández-Ruiz M, López-Medrano F, San Juan R, Lizasoain M, Ruiz-Merlo T, Morales-Cartagena A, Maestro G, Parra P, Villa J, Delgado R, Aguado JM.
    Clin Microbiol Infect; 2018 Apr 25; 24(4):414-421. PubMed ID: 28811244
    [Abstract] [Full Text] [Related]

  • 20. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
    Humphries RM, Uslan DZ, Rubin Z.
    J Clin Microbiol; 2013 Mar 25; 51(3):869-73. PubMed ID: 23269736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.